LabGenomics Statistics

Total Valuation

LabGenomics has a market cap or net worth of KRW 161.47 billion. The enterprise value is 146.13 billion.

Market Cap	161.47B
Enterprise Value	146.13B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

LabGenomics has 74.24 million shares outstanding. The number of shares has increased by 0.60% in one year.

Current Share Class	74.24M
Shares Outstanding	74.24M
Shares Change (YoY)	+0.60%
Shares Change (QoQ)	-0.14%
Owned by Insiders (%)	0.53%
Owned by Institutions (%)	5.93%
Float	61.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.81
PB Ratio	0.86
P/TBV Ratio	1.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.08
EV / Sales	1.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.14

Financial Position

The company has a current ratio of 1.83, with a Debt / Equity ratio of 0.26.

Current Ratio	1.83
Quick Ratio	1.74
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	-1.75
Interest Coverage	-6.12

Financial Efficiency

Return on equity (ROE) is -17.58% and return on invested capital (ROIC) is -8.34%.

Return on Equity (ROE)	-17.58%
Return on Assets (ROA)	-7.51%
Return on Invested Capital (ROIC)	-8.34%
Return on Capital Employed (ROCE)	-16.54%
Revenue Per Employee	629.32M
Profits Per Employee	-252.19M
Employee Count	142
Asset Turnover	0.32
Inventory Turnover	15.91

Taxes

Income Tax	-6.65B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.35% in the last 52 weeks. The beta is -0.10, so LabGenomics's price volatility has been lower than the market average.

Beta (5Y)	-0.10
52-Week Price Change	-13.35%
50-Day Moving Average	2,266.40
200-Day Moving Average	2,366.80
Relative Strength Index (RSI)	44.55
Average Volume (20 Days)	698,809

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LabGenomics had revenue of KRW 89.36 billion and -35.81 billion in losses. Loss per share was -480.21.

Revenue	89.36B
Gross Profit	31.37B
Operating Income	-33.66B
Pretax Income	-42.46B
Net Income	-35.81B
EBITDA	-23.10B
EBIT	-33.66B
Loss Per Share	-480.21

Full Income Statement

Balance Sheet

The company has 64.98 billion in cash and 49.64 billion in debt, giving a net cash position of 15.34 billion or 206.68 per share.

Cash & Cash Equivalents	64.98B
Total Debt	49.64B
Net Cash	15.34B
Net Cash Per Share	206.68
Equity (Book Value)	188.67B
Book Value Per Share	2,547.69
Working Capital	51.09B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -27.45 billion and capital expenditures -987.52 million, giving a free cash flow of -28.44 billion.

Operating Cash Flow	-27.45B
Capital Expenditures	-987.52M
Free Cash Flow	-28.44B
FCF Per Share	-383.07

Full Cash Flow Statement

Margins

Gross margin is 35.10%, with operating and profit margins of -37.67% and -40.07%.

Gross Margin	35.10%
Operating Margin	-37.67%
Pretax Margin	-47.51%
Profit Margin	-40.07%
EBITDA Margin	-25.85%
EBIT Margin	-37.67%
FCF Margin	n/a

Dividends & Yields

LabGenomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.60%
Shareholder Yield	-0.60%
Earnings Yield	-22.18%
FCF Yield	-17.61%

Dividend Details

Stock Splits

The last stock split was on August 7, 2023. It was a forward split with a ratio of 2.

Last Split Date	Aug 7, 2023
Split Type	Forward
Split Ratio	2

Scores

LabGenomics has an Altman Z-Score of 2.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.32
Piotroski F-Score	3